Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18951
Title: Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
Austin Authors: Ngo, Brian ;Papa, Nathan P;Perera, Marlon ;Bolton, Damien M ;Sengupta, Shomik 
Affiliation: Department of Urology, Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia
Issue Date: May-2017
Publication information: BJU International 2017; 119 Suppl 5: 19-25
Abstract: To identify factors that impact on the timeliness and adequacy of haematuria evaluation. We undertook a retrospective cohort study identifying patients who underwent cystoscopy for investigation of haematuria at our institution between 1 January 2015 and 31 December 2015. Data on patient demographics, smoking status, anticoagulation, type of haematuria and referring clinician were collected. Exclusion criteria included patient age <18 years, known history of bladder/urinary tract/renal cancer, cystoscopy for indications other than haematuria and unknown date of urology consultation. Primary outcome measures were: i) time from general practitioner (GP) referral to urology consultation, ii) time from urology consultation to cystoscopy, and iii) receipt of investigations in the 180 days prior to cystoscopy. Comparisons between risk factors were carried out using negative binomial regression for count outcomes and chi-square test for categorical outcomes. Over the study period, 305 eligible cases (225 men, 80 women) were identified, of which 196 (64%) were referred by a GP. Patients waited a median of 38 days from GP referral to urology consultation and 28 days from urology consultation to cystoscopy. The median time to urology consultation was 65 days for women and 33.5 days for men (P = 0.020). However, the observed difference between men and women was no longer statistically significant on multivariable regression, with the only independent predictors of a shorter interval being visible haematuria and imaging suspicious for cancer. Anticoagulated patients were more likely to have imaging studies, in particular renal tract ultrasonography (P = 0.006), while only 61% of patients with visible haematuria received imaging. No significant differences in recent investigations between genders were observed. Gender is not a significant predictor of delayed haematuria assessment or receipt of recent investigations. Anticoagulated patients are more likely to receive imaging than patients without anticoagulation and patients with visible haematuria are not adequately imaged. Improved clinician and public education is required to ensure that all patients are evaluated appropriately.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18951
DOI: 10.1111/bju.13809
ORCID: 0000-0002-3188-1803
0000-0002-1138-6389
0000-0002-5145-6783
0000-0003-3357-1216
PubMed URL: 28544302
Type: Journal Article
Subjects: cystoscopy
diagnosis
haematuria
time factors
timeliness
urinary bladder neoplasm
urology
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Nov 29, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.